Uncategorized

New Article: New Compound Shows Potential for Triple-Negative Breast Cancer

Researchers at the University of Michigan have identified a promising new drug compound for targeting one of the most aggressive types of breast cancer.  The compound, currently called UM-164, goes after a kinase known to play a role in the growth and spread of triple-negative breast cancer. UM-164 blocks the kinase c-Src and inhibits another …

New Article: New Compound Shows Potential for Triple-Negative Breast Cancer Read More »

Scroll to Top